The Blanche and Irwin Lerner Center

Alumni prove to be valuable resource for Pharma MBA student researchers

Wednesday, July 16, 2014

When Rutgers Business School alumnus Mark Slomiany heard that students from the MBA pharmaceutical management program were hoping to produce academic research on issues facing the biopharmaceutical industry, he had an idea about how to help them.    

TAGS: Mahmud Hassan MBA Pharmaceutical Management Research Rutgers Business School Alumni Association The Blanche and Irwin Lerner Center

Lerner healthcare symposium "validates what we're learning"

Date: 
Thursday, May 15, 2014
Location: 
Newark, NJ

At the annual healthcare symposium sponsored by Rutgers Business School's Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues, many classroom lectures and lessons became a little more meaningful.

"We hear about the theory, the legislation, the big picture," said Michael  Kwatkoski, an MBA student in the Pharmaceutical Management Program. "Something like this puts in all in practical perspective."

The April 30 symposium, "Global Challenges to Pharmaceutical Reimbursements," provided a big-picture, real-world look at the federal government's efforts to reduce healthcare costs while increasing access to medical care. Jonathan Blum, principal deputy administrator at the Centers for Medicare and Medicaid Services, gave the keynote address. Gail Wilensky, a senior fellow from Project Hope, also spoke about the Affordable Care Act.

In a panel discussion moderated by Richard Bagger, a senior vice president at Celgene, a trio of pharmaceutical executives shared their insights about how the new focus on pricing and affordability is impacting the industry's business model – namely the strategy of how companies decide what new medicines to spend time and money developing and taking to market.

The annual symposium is the Lerner Center's signature event, reinforcing its role as a source of thought leadership on issues impacting the pharmaceutical and healthcare businesses. This year's symposium attracted a crowd of more than 70 students, alumni, industry professionals, corporate supporters and media.

In his opening remarks, Professor Mahmud Hassan, the center's director, highlighted some of the strengths of the Rutgers MBA Pharmaceutical Management Program – including the high percentage of graduates who are employed by the industry after completing their MBAs – and how the program benefits from the presence of the 10-year-old Lerner Center. 

Hassan said the goal of the symposium was to produce a "meaningful dialogue" relevant to the growth of the biopharmaceutical industry.

Kwatkoski, who is studying pharmaceutical management and marketing, sat through the three-hour event, absorbing the information and insights. "I enjoyed hearing the perspective of people who have worked in pharma for so many years," he said.

Javiar Rodriguez, a former pharmacist turned MBA student, also said the symposium enriched his studies with practical insights.

"These events bring the real world to us," Rodriguez said. "It validates what we're learning."

Full Article

TAGS: Mahmud Hassan Pharmaceutical Management The Blanche and Irwin Lerner Center Thought Leadership

Thought leaders tackle healthcare reform and pharma's changing business model in Lerner Center's annual symposium

Monday, May 5, 2014

With his first year of graduate studies nearly behind him, Michael Kwatkoski has sat through hours of lessons on the pharmaceutical business and the nation’s healthcare system.

TAGS: Alumni Mahmud Hassan MBA Pharmaceutical Management Sharon Lydon The Blanche and Irwin Lerner Center Thought Leadership

Rutgers Business School takes honorable mention at second annual biopharmaceutical case competition

Monday, November 18, 2013

A team of Rutgers MBA students won honorable mention in the second annual biopharmaceutical case competition hosted at Rutgers Business School on Nov. 15.

TAGS: Case Competition Mahmud Hassan MBA Networking Pharmaceutical Management The Blanche and Irwin Lerner Center

Mahmud Hassan interviewed about drugmaker Merck's facilities and staff reorganization

Date: 
Wednesday, October 2, 2013
Location: 
Newark, NJ

In a statement about its global cost-cutting plan, Merck, the second-largest U.S. drugmaker said the cuts were part of an effort to sharpen “commercial and R&D (research and development) focus and reduce costs,” including the size of its workforce and global real estate footprint.

In a conference call, Merck Chief Executive Ken Frazier said the company will place more emphasis on developing drugs with the most sales potential, which means getting the business side to work more closely with researchers, he said. But Rutgers Business School professor Mahmud Hassan wondered what took so long. “Merck’s been limping along for the last several years, relying on one drug, Januvia,” he said. Sales of that blockbuster diabetes medication are now being threatened as several new competitors are in the final stages of development or scheduled to debut their own versions in the next two years.

Hassan added that Merck’s decision to lay off thousands of workers was a short-term fix, and that trying to sell off properties will be a difficult proposition in the current economy.

Full article

TAGS: Mahmud Hassan Merck The Blanche and Irwin Lerner Center

Rutgers Pharma MBA ranked one of the Top 10 MBA programs in pharmaceuticals in the world

Monday, September 30, 2013

Rutgers Business School’s MBA in Pharmaceutical Management has been recognized as one of the top 10 MBA programs for Health Care/Pharmaceuticals/Biotechnology in the world according to Find-MBA.com.

TAGS: MBA Pharmaceutical Management Rankings The Blanche and Irwin Lerner Center Traditional Full-Time MBA

Irwin Lerner, who started the Lerner Center at RBS, has high hopes for student research and merger with UMDNJ

Friday, May 3, 2013

Irwin Lerner, the man behind the Blanche and Irwin Lerner Center for the study of Pharmaceutical Management Issues, retired as chairman and chief executive of Roche’s U.S. business in 1992.

Lerner spent 32 years with the drug maker, starting as director of advertising in 1980 when Valium was on the verge of being launched.

TAGS: Mahmud Hassan MBA Pharmaceutical Management The Blanche and Irwin Lerner Center

Healthcare symposium promises to take a hard look at the complex issues facing bio-pharmaceutical industry

Monday, April 22, 2013

The Food and Drug Administration is still waiting for pharmaceutical companies to begin submitting the first new medicines in a class of prescription drugs known as biosimilars, according to Rachel Sherman, an official with the agency’s Center for Drug Evaluation and Research.

TAGS: Healthcare Symposium Mahmud Hassan MBA Pharmaceutical Management The Blanche and Irwin Lerner Center

Faculty Insight: Ruling by federal appeals court creates new wrinkle for pharmaceutical industry and authorities

Monday, December 17, 2012

A recent decision by a federal appeals court has put a new spotlight on the pharmaceutical industry’s controversial off-label marketing practices by providing the industry – if the ruling holds up – with some constitutional leeway when its sales reps promote medicines for unapproved uses.

TAGS: Faculty Insights Michael Santoro Pharmaceutical Management The Blanche and Irwin Lerner Center Thought Leadership

Sanofi's Anne Whitaker on leadership and agility during revolutionary change in pharmaceutical industry

Friday, October 26, 2012

There are times when Sanofi executive Anne Whitaker -- and lots of other executives for that matter -- might like to have a GPS to help steer their companies through the changes transforming the pharmaceutical industry.

Instead, they have to rely on their leadership skills.

“When you’re in a changing environment, you can’t take a GPS,’’ Whitaker said during a recent talk at the Rutgers Business School. “You have to have enough of a vision so that people trust that you know where you’re taking them.”

TAGS: CEO Lecture Series MBA The Blanche and Irwin Lerner Center

Rutgers Business School to host its first biopharmaceutical case competition

Tuesday, October 23, 2012

Nearly a year after one of its teams of MBA students swept one of the most prestigious pharmaceutical case competitions in the country, Rutgers Business School is turning host.

TAGS: Mahmud Hassan MBA Pharmaceutical Management Club The Blanche and Irwin Lerner Center

Richard Bagger, veteran pharmaceutical executive, joins Lerner Center's advisory board

Thursday, October 11, 2012

Richard Bagger, who served as Gov. Chris Christie’s first chief of staff, has joined the board of advisors for the Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.

Bagger, an attorney, spent more than a decade in the state Legislature, first as an assemblyman and then as a state senator.  Before becoming Gov. Christie’s chief of staff, he worked as Pfizer’s senior vice president of worldwide public affairs and policy.  

TAGS: Executive MBA MBA The Blanche and Irwin Lerner Center

Final Thoughts from Sol J. Barer at the Rutgers Healthcare Symposium (Part 5 of 5)

Date: 
Thursday, April 21, 2011
Location: 
Newark, NJ

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.

TAGS: Health Care The Blanche and Irwin Lerner Center Video

Keynote Speaker Sol J. Barer at the Rutgers Healthcare Symposium (Part 4 of 5)

Date: 
Thursday, April 21, 2011
Location: 
Newark, NJ

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.

TAGS: Health Care The Blanche and Irwin Lerner Center Video

Opening remarks by Dean Glenn Shafer and more at the Rutgers Healthcare Symposium (Part 3 of 5)

Date: 
Thursday, April 21, 2011
Location: 
Newark, NJ

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.

TAGS: Health Care The Blanche and Irwin Lerner Center Video

Welcome Address by President Richard McCormick at the Rutgers Healthcare Symposium (Part 2 of 5)

Date: 
Thursday, April 21, 2011
Location: 
Newark, NJ

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.

TAGS: Health Care The Blanche and Irwin Lerner Center Video

Introduction by Dr. Mahmud Hassan at the Rutgers Healthcare Symposium (Part 1 of 5)

Date: 
Thursday, April 21, 2011
Location: 
Newark, NJ

The Annual Healthcare Symposium: "Problems and Prospects of the Pharmaceutical Industry" was held on Thursday, April 21, 2011 at Rutgers Business School in Newark, NJ. The event was made possible by The Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues.

TAGS: Health Care The Blanche and Irwin Lerner Center Video

Syndicate content